NEUROENDOCRINE CARCINOMA OF PROSTATE

NEUROENDOCRINE CARCINOMA OF PROSTATE was reported 68 times

NEUROENDOCRINE CARCINOMA OF PROSTATE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DAROLUTAMIDE 8 0.0014
1 LAROTRECTINIB 1 0.0011
2 CABAZITAXEL 3 0.0009
3 BICALUTAMIDE 12 0.0008
4 DEGARELIX 4 0.0008
5 TRIPTORELIN 2 0.0006
6 DOCETAXEL 22 0.0003
7 DOCETAXEL ANHYDROUS 22 0.0003
8 ABIRATERONE ACETATE 12 0.0003
9 LEUPROLIDE ACETATE 17 0.0002
10 CALCIUM FOLINATE 1 0.0002
11 ETOPOSIDE 15 0.0002
12 MANNITOL 1 0.0002
13 ALISKIREN HEMIFUMARATE 1 0.0002
14 ENZALUTAMIDE 7 0.0001
15 TERAZOSIN HYDROCHLORIDE 1 0.0001
16 OLAPARIB 2 0.0001
17 APALUTAMIDE 1 0.0001
18 PACLITAXEL 8 0.0001
19 LABETALOL 1 0.0001
20 GOSERELIN 1 0.0001
21 CISPLATIN 5 0.0001
22 CARBOPLATIN 8 0.0001
23 EVEROLIMUS TABLETS 1 0.0001
24 DURVALUMAB 1 0.0000
25 ANTI-ITCH CREAM 2 0.0000
26 HYDROCORTISONE LOTION 2 0.0000
27 HYDROCORTISONE CREAM 1% 2 0.0000
28 HYDROCORTISONE ACETATE 2 0.0000
29 HYDROCORTISONE 2 0.0000
30 EVEROLIMUS 1 0.0000
31 RANITIDINE HYDROCHLORIDE 1 0.0000
32 OXALIPLATIN 1 0.0000
33 FLUOROURACIL CREAM, 0.5% 1 0.0000
34 FLUOROURACIL 1 0.0000
35 PREDNISOLONE ORAL SOLUTION 2 0.0000
36 POTASSIUM CHLORIDE ORAL 1 0.0000
37 USTEKINUMAB 1 0.0000
38 PEMBROLIZUMAB 1 0.0000
39 POTASSIUM CHLORIDE 1 0.0000
40 PREDNISONE 4 0.0000
41 CARVEDILOL 1 0.0000
42 SPIRONOLACTONE 1 0.0000
43 AMLODIPINE 1 0.0000
44 FUROSEMIDE 1 0.0000